Mercado global de tratamento do herpes labial – Tendências do setor e previsão para 2030

Pedido de resumo Pedido de TOC Fale com Analista Fale com o analista  Comprar agora Comprar agora Consulte antes Comprar Consulte antes Relatório de amostra grátis Relatório de amostra grátis

Mercado global de tratamento do herpes labial – Tendências do setor e previsão para 2030

  • Pharmaceutical
  • Upcoming Reports
  • Nov 2023
  • Global
  • 350 Páginas
  • Número de tabelas: 220
  • Número de figuras: 60

Global Cold Sore Treatment Market

Tamanho do mercado em biliões de dólares

CAGR :  % Diagram

Diagram Período de previsão
2023 –2030
Diagram Tamanho do mercado (ano base )
USD 825.24 Million
Diagram Tamanho do mercado ( Ano de previsão)
USD 1,376.06 Million
Diagram CAGR
%
Diagram Principais participantes do mercado
  • Manequim1
  • Manequim2
  • Manequim3
  • Manequim4
  • Manequim5

>Mercado global de tratamento do herpes labial, tipo de estirpe (vírus herpes simplex tipo 1, vírus herpes simplex tipo 2), tipo terapêutico (agentes antivirais, agentes analgésicos, outros), tipo de medicamento (marca, genéricos), forma de dosagem ( comprimido, cápsula , Pomada, Outros), Via de Administração (Oral, Tópica, Outros), Utentes Finais (Hospitais, Clínicas Especializadas, Homecare, Outros), Canal de Distribuição (Farmácia Hospitalar, Farmácia de Retalho, Farmácia Online, Outros) - Tendências e Previsão do Sector para 2030.

Mercado de tratamento do herpes labial

Análise e tamanho do mercado de tratamento do herpes labial

De acordo com as estatísticas da Organização Mundial de Saúde, em 2020, cerca de 3,7 milhões de pessoas em todo o país foram infetadas pelo HSV 1. O contacto direto com a pele ou saliva infetada transmite o vírus HSV-1. A infeção primária pode causar febre, dores nas gengivas, dor de garganta e glândulas inchadas ou irritadas no pescoço nas crianças. O vírus fica então latente nas raízes nervosas junto à pele afetada. O vírus raramente, ou nunca, é reativado em determinadas pessoas. As recorrências do vírus, conhecidas como episódios secundários de herpes, podem ocorrer em certas pessoas, resultando em herpes labial. Embora o motivo exato da reativação ainda não tenha sido descoberto, uma série de fatores, como o stress, o tratamento dentário, a doença, o trauma labial ou a exposição solar, podem desencadear um surto.

A Data Bridge Market Research analisa que o mercado de tratamento do herpes labial foi avaliado em 825,24 milhões de dólares em 2022 e deverá atingir os 1.376,06 milhões de dólares até 2030, registando um CAGR de 6,60% durante o período de previsão de 2023 a 2030. '”Agentes antivirais” domina o segmento de tipo terapêutico no mercado, uma vez que a maior parte das constipações é causada por febre viral comum.

Além dos insights de mercado, tais como o valor de mercado, a taxa de crescimento, os segmentos de mercado, a cobertura geográfica, os participantes do mercado e o cenário de mercado, o relatório de mercado com curadoria da equipa de pesquisa de mercado da Data Bridge também inclui análises especializadas aprofundadas , epidemiologia do doente, pipeline analysis, análise de preços e enquadramento regulamentar.

Para além dos insights sobre os cenários de mercado, tais como o valor de mercado, a taxa de crescimento, a segmentação, a cobertura geográfica e os grandes players, os relatórios de mercado com curadoria da Data Bridge Market Research incluem também análises especializadas aprofundadas, produção geograficamente representada pela empresa e capacidade, layouts de rede de distribuidores e parceiros, análise detalhada e atualizada das tendências de preços e análise do défice da cadeia de abastecimento e da procura.

Âmbito do relatório e segmentação de mercado

Métrica de reporte

Detalhes

Período de previsão

2023 a 2030

Ano base

2022

Anos históricos

2021 (personalizável para 2015-2020)

Unidades Quantitativas

Receita em milhões de dólares, volumes em unidades, preços em dólares

Segmentos cobertos

Tipo de estirpe (vírus herpes simplex tipo 1, vírus herpes simplex tipo 2), tipo terapêutico (agentes antivirais, agentes analgésicos, outros), tipo de medicamento (marca, genérico), forma farmacêutica (comprimido, cápsula, pomada, outros), Via de Administração (Oral, Tópica, Outros), Utentes Finais (Hospitais, Clínicas Especializadas, Homecare, Outros), Canal de Distribuição (Farmácia Hospitalar, Farmácia de Retalho, Farmácia Online, Outros)

Países abrangidos

EUA, Canadá e México na América do Norte, Alemanha, França, Reino Unido, Holanda, Suíça, Bélgica, Rússia, Itália, Espanha, Turquia, Resto da Europa na Europa, China, Japão, Índia, Coreia do Sul, Singapura, Malásia , Austrália, Tailândia, Indonésia, Filipinas, Resto da Ásia-Pacífico (APAC) na Ásia-Pacífico (APAC), Arábia Saudita, Emirados Árabes Unidos, África do Sul, Egito, Israel, Resto do Médio Oriente e África (MEA) como parte do Médio Oriente e África (MEA), Brasil, Argentina e Resto da América do Sul como parte da América do Sul

Participantes do mercado abrangidos

(EUA), GlaxoSmithKline plc (Reino Unido), Novartis AG (Suíça), Mylan NV (EUA), Teva Pharmaceutical Industries Ltd. (Israel), Sanofi (França), AstraZeneca (Reino Unido), Johnson & Johnson Private Limited ( EUA ), Merck & Co., Inc. (EUA), F. Hoffmann-La Roche Ltd. (Suíça), Cipla Inc. Company (EUA), Gilead Sciences, Inc. (EUA), Bayer AG (Alemanha), Eli Lilly and Company (EUA), Sun Pharmaceutical Industries Ltd. Health Companies Inc. (Canadá)

Oportunidades de mercado

  • Falta de medicamentos obriga a novos medicamentos
  • Avanço tecnológico

Definição de mercado

A afta é uma bolha cheia de líquido que ocorre nos lábios ou à volta da boca. Bolhas de febre, herpes oral e herpes labial são termos utilizados para descrever o herpes labial. O herpes simplex é o vírus que os causa. O vírus herpes simplex 1 é a estirpe mais prevalente do vírus que causa o herpes labial. As pomadas antivirais, incluindo o aciclovir e o penciclovir, são aplicadas nas feridas como parte do tratamento. Estes podem funcionar para algumas pessoas, mas são frequentemente ineficazes. Os medicamentos antivirais orais, como o famciclovir, o aciclovir e o valaciclovir, podem ajudar a reduzir a duração e a gravidade das feridas. Os sintomas podem ser aliviados com a aplicação de analgésicos de venda livre nas feridas (tópicos). Os medicamentos anti-inflamatórios podem ser potencialmente benéficos.

Dinâmica global do mercado de tratamento do herpes labial

Motoristas

  • Elevada taxa de prevalência de infeção por HSV

A crescente prevalência da infecção por HSV em todo o mundo actuará como um grande impulsionador que resultará na expansão da taxa de crescimento do mercado. Em pessoas com doenças crónicas ou de longa duração, o HSV aumenta a hipótese de adquirir e transmitir a infeção pelo VIH e pode causar complicações significativas, como encefalite e queratite. Isto, combinado com o número crescente de doentes com doenças crónicas, é um dos principais factores que impulsionam a procura de terapêutica para o HSV em todo o mundo.

  • Aumentar o investimento em infraestruturas de saúde

Outro fator significativo que influencia a taxa de crescimento do mercado de tratamento do herpes labial é o aumento dos gastos com a saúde, o que ajuda a melhorar as suas infraestruturas. Além disso, várias organizações governamentais pretendem melhorar a infra-estrutura de saúde através do aumento do financiamento e isto influenciará ainda mais a dinâmica do mercado.

Além disso, um número crescente de iniciativas governamentais para difundir a consciencialização e aumentar a população geriátrica irá expandir o mercado do tratamento do herpes labial. Além disso, o aumento do nível de rendimento disponível e as crescentes iniciativas favoráveis ​​do governo aumentarão a taxa de crescimento do mercado.

Oportunidade

  • Falta de pedidos de medicamentos para novos medicamentos 

O crescimento do mercado é alimentado pela falta de encomendas de novos medicamentos. Isto proporcionará oportunidades benéficas para o crescimento do mercado de tratamento do herpes labial. Existem apenas alguns medicamentos disponíveis para tratar a afta no mercado. Isto incentiva as empresas farmacêuticas a produzir novos medicamentos. Os jogadores estão a fazê-lo incorporando novas tecnologias que lhes permitirão isolar a molécula para tratamento. Além disso, as questões de manutenção da farmacocinética e farmacodinâmica ideais dos medicamentos estão a proporcionar às empresas farmacêuticas oportunidades lucrativas.

Além disso, o crescimento do mercado é alimentado pelo investimento para desenvolver tecnologias avançadas e aumentar o número de mercados emergentes. Estes fatores proporcionarão oportunidades benéficas para o crescimento do mercado de tratamento do herpes labial.

Restrição/Desafio

  • Elevado custo associado ao tratamento

Por outro lado, o elevado custo associado ao tratamento irá obstruir a taxa de crescimento do mercado de Tratamento do herpes labial durante 2023-2030. A falta de infraestruturas de saúde nas economias em desenvolvimento e o cenário regulamentar rigoroso desafiarão o mercado de tratamento do herpes labial. Além disso, a falta de sensibilização entre as pessoas e as más políticas de reembolso restringirão e impedirão ainda mais a taxa de crescimento do mercado durante o período de previsão de 2023-2030.

Este relatório de mercado de tratamento do herpes labial fornece detalhes dos novos desenvolvimentos recentes, regulamentos comerciais, análise de importação-exportação, análise de produção, otimização da cadeia de valor, quota de mercado, impacto dos participantes do mercado nacionais e localizados, analisa as oportunidades em termos de bolsas de receitas emergentes, alterações nas regulamentações do mercado, análise estratégica do crescimento do mercado, tamanho do mercado, crescimento do mercado por categoria, nichos de aplicação e domínio, aprovações de produtos, lançamentos de produtos, expansões geográficas, inovações tecnológicas no mercado. Para mais informações sobre o mercado de tratamento do herpes labial, contacte a Data Bridge Market Research para obter um resumo do analista, a nossa equipa irá ajudá-lo a tomar uma decisão de mercado informada para alcançar o crescimento do mercado.

Este relatório de mercado de tratamento do herpes labial fornece detalhes dos novos desenvolvimentos recentes, regulamentos comerciais, análise de importação-exportação, análise de produção, otimização da cadeia de valor, quota de mercado, impacto dos participantes do mercado nacionais e localizados, analisa as oportunidades em termos de bolsas de receitas emergentes, alterações nas regulamentações do mercado, análise estratégica do crescimento do mercado, tamanho do mercado, crescimento do mercado por categoria, nichos de aplicação e domínio, aprovações de produtos, lançamentos de produtos, expansões geográficas, inovações tecnológicas no mercado. Para mais informações sobre o mercado de tratamento do herpes labial, contacte a Data Bridge Market Research para obter um resumo do analista, a nossa equipa irá ajudá-lo a tomar uma decisão de mercado informada para alcançar o crescimento do mercado.

Desenvolvimento recente

  • Em julho de 2021, a Devirex anunciou o lançamento do lipivir. A Devirex inicia uma nova fase de desenvolvimento: o que foi desenvolvido em laboratório será gradualmente distribuído para outros mercados. O gel labial Lipivir(R), que previne o herpes labial, estava disponível em farmácias, drogarias, spas de beleza e online no início de 2021 na Suíça e na Áustria, após centenas de horas de criação, investigação e análise

 Âmbito global do mercado de tratamento do herpes labial

O mercado de tratamento do herpes labial está segmentado com base no tipo de estirpe, tipo terapêutico, tipo de medicamento, forma farmacêutica, via de administração, utilizadores finais e canal de distribuição. O crescimento entre estes segmentos irá ajudá-lo a analisar os escassos segmentos de crescimento nas indústrias e fornecer aos utilizadores uma valiosa visão geral do mercado e insights de mercado para os ajudar a tomar decisões estratégicas para identificar as principais aplicações do mercado.

Tipo de tensão

  • Vírus Herpes Simplex Tipo 1
  • Vírus Herpes Simplex Tipo 2

Tipo Terapêutico

  • Agentes Antivirais
  • Aciclovir
  • Valaciclovir
  • Fanciclovir
  • Penciclovir
  • Agentes Analgésicos
  • Lisina
  • Ruibarbo e sálvia
  • Própolis
  • Outros

Tipo de droga

  • Com marca
  • Genéricos

Forma farmacêutica

  • Comprimido
  • Cápsula
  • Pomada
  • Outros

Rota de Administração

  • Oral
  • Tópico
  • Outros

Utilizadores finais

  • Hospitais
  • Clínicas Especializadas
  • Cuidados domiciliários
  • Outros

Canal de distribuição

  • Farmácia Hospitalar
  • Farmácia de Retalho
  • Farmácia on-line
  • Outros

Análise/perspetivas regionais do mercado global de tratamento do herpes labial

O mercado de tratamento do herpes labial é analisado e são fornecidos insights e tendências de tamanho de mercado por país, tipo de estirpe, tipo terapêutico, tipo de medicamento, forma farmacêutica, via de administração, utilizadores finais e canal de distribuição como mencionado acima.

Os países abrangidos no relatório global do mercado de tratamento do herpes labial são os EUA, Canadá e México na América do Norte, Alemanha, França, Reino Unido, Holanda, Suíça, Bélgica, Rússia, Itália, Espanha, Turquia, resto da Europa, China , Japão, Índia , Coreia do Sul, Singapura, Malásia, Austrália, Tailândia, Indonésia, Filipinas, resto da Ásia-Pacífico, Arábia Saudita, Emirados Árabes Unidos, África do Sul, Egipto, Israel, resto do Médio Oriente e África, Brasil , Argentina e resto da América do Sul .

A América do Norte domina o mercado de tratamento do herpes labial em termos de quota de mercado e receitas de mercado e continuará a florescer o seu domínio durante o período de previsão. Isto deve-se à crescente população-alvo e ao aumento dos gastos com a saúde irá impulsionar ainda mais a taxa de crescimento do mercado nesta região. Além disso, a presença dos principais intervenientes e a crescente consciencialização dos consumidores sobre as doenças DST impulsionarão ainda mais a taxa de crescimento do mercado nesta região.

Prevê-se que a Ásia-Pacífico seja a região de crescimento mais rápido durante o período de previsão de 2023-2030 devido ao número crescente de população de doentes nesta região. Além disso, o desenvolvimento da infra-estrutura de saúde e o aumento das iniciativas governamentais impulsionarão ainda mais a taxa de crescimento do mercado nesta região.

A secção do país do relatório também fornece fatores individuais de impacto no mercado e alterações na regulamentação do mercado interno que impactam as tendências atuais e futuras do mercado. Pontos de dados como a análise da cadeia de valor a jusante e a montante, tendências técnicas e análise das cinco forças de Porter, estudos de caso são alguns dos indicadores utilizados para prever o cenário de mercado para países individuais. Além disso, são considerados a presença e disponibilidade de marcas globais e os desafios enfrentados devido à grande ou escassa concorrência de marcas locais e nacionais, o impacto das tarifas nacionais e das rotas comerciais, ao mesmo tempo que se fornece uma análise de previsão dos dados do país.

Base instalada de crescimento da infraestrutura de saúde e penetração de novas tecnologias

O mercado global de produtos de higiene feminina também fornece uma análise de mercado detalhada para o crescimento de cada país em termos de despesas de saúde para equipamentos de capital, base instalada de diferentes tipos de produtos para o mercado, o impacto da tecnologia utilizando curvas de salvação e alterações nos cenários regulamentares de saúde e o seu impacto no mercado no período histórico de 2011-2021.

Análise do cenário competitivo e da quota de mercado do tratamento do herpes labial

O panorama competitivo do mercado de tratamento do herpes labial fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença global, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa , lançamento de produto, largura e amplitude do produto, aplicação domínio. Os dados acima fornecidos estão apenas relacionados com o foco das empresas em relação ao mercado.

Alguns dos principais players que trabalham no mercado de tratamento do herpes labial são:

  • (EUA)
  • GlaxoSmithKline plc (Reino Unido)
  • Novartis AG (Suíça)
  • Mylan NV (EUA),
  • (Israel)
  • Sanofi (França)
  • AstraZeneca (Reino Unido)
  • Johnson & Johnson Private Limited (EUA)
  • Merck & Co., Inc.
  • F. Hoffmann-La Roche Ltd. (Suíça)
  • (EUA)
  • (EUA)
  • BD (EUA)
  • Empresa Bristol-Myers Squibb (EUA)
  • (EUA)
  • Bayer AG (Alemanha)
  • Eli Lilly and Company (EUA)
  • Sun Pharmaceutical Industries Ltd. (Índia)
  • Aurobindo Pharma (Índia)
  • Lupin (Índia)
  • Bausch Health Companies Inc. (Canadá)


SKU-

Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo

  • Painel interativo de análise de dados
  • Painel de análise da empresa para oportunidades de elevado potencial de crescimento
  • Acesso de analista de pesquisa para personalização e customização. consultas
  • Análise da concorrência com painel interativo
  • Últimas notícias, atualizações e atualizações Análise de tendências
  • Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Pedido de demonstração

Índice

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of GLOBAL Cold Sore Treatment MARKET
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. THERAPEUTICS LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. vendor share analysis
    11. MARKET drug type COVERAGE GRID
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. Pipeline analysis
  5. Epidemiology
  6. market overview
    1. drivers
      1. Growing prevalence of cold sore infection
      2. Proliferation in modes of transmission of herpes simplex virus
      3. Increasing awareness about sexually transmitted diseases
      4. Availability of generic drugs
      5. Rising rate of HSV infection among women
    2. RESTRAINTS
      1. Patent termination of marketed drugs
      2. Risks of other diseases associated with cold sore
      3. Dearth of awareness about the onset and symptoms of cold sore treatment
    3. OPPORTUNITIES
      1. Increasing disposable income
      2. Strategic Initiatives by market players
      3. Increasing research and Development
      4. Increasing use of cold sore patches
    4. CHALLENGES
      1. Rise in alternative treatments
      2. Emergence of drugs resistant to acyclovir
      3. Side effects Associated with medications used for treating cold sore
  7. COVID-19 IMPACT ON GLOBAL COLD SORE TREATMENT MARKET
    1. impact on price
    2. Impact on demand
    3. IMPACT ON SUPPLY CHAIN
    4. strategic decisions for manufacturers
    5. CONCLUSION
  8. global COLD SORE TREATMENT MARKET, BY strain TYPE
    1. overview
    2. HERPES SIMPLEX TYPE 1 VIRUS
    3. HERPES SIMPLEX TYPE 2 VIRUS
  9. global COLD SORE TREATMENT MARKET, BY therapeutics
    1. overview
    2. ANTIVIRAL AGENTS
      1. Acyclovir
      2. Famciclovir
      3. Penciclovir
      4. Valacyclovir
      5. Docosanol
    3. ANALGESIC AGENTS
      1. Carmex
      2. Herpecin
      3. others
    4. others
  10. global COLD SORETREATMENT MARKET, BY drug type
    1. overview
    2. generics
      1. otc
    3. branded
      1. prescription
      2. otc
  11. global COLD SORE TREATMENT MARKET, BY dosage type
    1. overview
    2. Oral
    3. Tablets
    4. Pills
    5. TOPICAL
      1. cream
      2. Ointments
      3. Gel
      4. spray
    6. others
  12. global COLD SORE TREATMENT MARKET, BY end user
    1. overview
    2. HOme care
    3. HOspitals
    4. SPECIALTY CLINICS
    5. OTHERS
  13. global COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL
    1. overview
    2. Hospitals Pharmacy
    3. online Pharmacy
    4. RETAIL Pharmacy
  14. GLOBAL Cold sore treatment market, by Geography
    1. overview
    2. NORTH AMERICA
      1. U.S.
      2. CANADA
      3. MEXICO
    3. EUROPE
      1. germany
      2. france
      3. U.K.
      4. ITALY
      5. SPAIN
      6. RUSSIA
      7. SWITZERLAND
      8. NETHERLAND
      9. TURKEY
      10. IRELAND
      11. BELGIUM
      12. POLAND
      13. AUSTRIA
      14. NORWAY
      15. HUNGARY
      16. LITHUANIA
      17. REST OF EUROPE
    4. Asia pacific
      1. China
      2. Japan
      3. India
      4. Australia
      5. South Korea
      6. Singapore
      7. Malaysia
      8. Philippiness
      9. Indonesia
      10. Thailand
      11. Vietnam
      12. Rest of Asia-Pacific
    5. South America
      1. Brazil
      2. Argentina
      3. Peru
      4. rest of south america
    6. MIDDLE EAST & AFRICA
      1. south africa
      2. egypt
      3. saudi arabia
      4. Israel
      5. uae
      6. kuwait
      7. rest of middle east & africa
  15. Global Cold Sore Treatment Market: COMPANY landscape
    1. company share analysis: global
    2. company share analysis: north america
    3. company share analysis: europe
    4. company share analysis: Asia-Pacific
  16. SWOT
  17. company profile
    1. GLAXOSMITHKLINE PLC
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    2. ORTHO DERMATOLOGICS’ (A DIVISION OF BAUSCH HEALTH COMPANIES INC.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    3. FOUNDATION CONSUMER HEALTHCARE
      1. COMPANY SNAPSHOT
      2. company share analysis
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    4. NOVARTIS AG
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    5. TEVA PHARMACEUTICALS USA, INC. (A SUBSIDIARY OF TEVA PHARMACEUTICAL INDUSTRIES LTD.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    6. AMNEAL PHARMACEUTICALS LLC
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    7. AICURIS GMBH & CO. KG
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    8. APOTEX INC.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    9. AUROBINDO PHARMA USA (A SUBSIDIARY OF AUROBINDO PHARMA)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    10. CIPLA LIMITED
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    11. GLENMARK PHARMACEUTICALS, INC., USA (A SUBSIDIARY OF GLENMARK PHARMACEUTICAL LTD.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    12. HIKMA PHARMACEUTICALS PLC
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    13. HRA PHARMA
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    14. HETERO HEALTHCARE LIMITED
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    15. JUBILANT CADISTA (A SUBSIDIARY OF JUBILANT LIFE SCIENCES LIMITED)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    16. MERIX PHARMACEUTICAL CORP.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    17. SQAUREX
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    18. SUN PHARMACEUTICAL INDUSTRIES LTD.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    19. VIATRIS INC.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    20. WOCKHARDT
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    21. Zydus Pharmaceuticals, Inc. (a subsidiary of Zydus Cadila)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
  18. questionnaire
  19. related reportS

Lista de Tabela

TABLE 1 GlobalCOLD SORE TREATMENT Market, pipeline analysis

TABLE 2 GENERIC DRUGS USED FOR THE TREATMENT OF HSV (COLD SORES)

TABLE 3 global COLD SORE TREATMENT Market, By strain TYPE 2019-2028 (USD Million)

TABLE 4 global HERPES SIMPLEX TYPE 1 VIRUS in COLD SORE TREATMENT Market, By Region, 2019-2028 (USD Million)

TABLE 5 globaL HERPES SIMPLEX TYPE 2 VIRUS in COLD SORE TREATMENT Market, By Region, 2019-2028 (USD Million)

TABLE 6 global COLD SORE TREATMENT Market, By THERAPEUTICS 2019-2028 (USD Million)

TABLE 7 global ANTIVIRAL AGENTS in COLD SORE TREATMENT Market, By region 2019-2028 (USD Million)

TABLE 8 global ANTIVIRAL AGENTS in COLD SORE TREATMENT Market, By therapeutics, 2019-2028 (USD Million)

TABLE 9 global ANALGESIC AGENTS in COLD SORE TREATMENT Market, By region, 2019-2028 (USD Million)

TABLE 10 global Analgesic AGENTS in COLD SORE TREATMENT Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 11 global others in COLD SORE TREATMENT Market, By region, 2019-2028 (USD Million)

TABLE 12 global COLD SORE TREATMENT Market, By drug type 2019-2028 (USD Million)

TABLE 13 global generics in COLD SORE TREATMENT Market, By Region, 2019-2028 (USD Million)

TABLE 14 global generics in COLD SORE TREATMENT Market, By drug type, 2019-2028 (USD Million)

TABLE 15 global branded in COLD SORE TREATMENT Market, By Region, 2019-2028 (USD Million)

TABLE 16 global branded in COLD SORE TREATMENT Market, By drug type, 2019-2028 (USD Million)

TABLE 17 global COLD SORE TREATMENT Market, By dosage type 2019-2028 (USD Million)

TABLE 18 global Oral in COLD SORE TREATMENT Market, By Region, 2019-2028 (USD Million)

TABLE 19 global Oral segment in COLD SORE TREATMENT Market, By dosage type, 2019-2028 (USD Million)

TABLE 20 global TOPICAL segment in COLD SORE TREATMENT Market, By Region, 2019-2028 (USD Million)

TABLE 21 global TOPICAL segment in COLD SORE TREATMENT Market, By dosage type, 2019-2028 (USD Million)

TABLE 22 global others in COLD SORE TREATMENT Market, By Region, 2019-2028 (USD Million)

TABLE 23 global COLD SORE TREATMENT Market, By END USER 2019-2028 (USD Million)

TABLE 24 global HOSPITALS in COLD SORE TREATMENT Market, By Region, 2019-2028 (USD Million)

TABLE 25 global HOspitals in COLD SORE TREATMENT Market, By Region, 2019-2028 (USD Million)

TABLE 26 global SPECIALTY CLINICS in COLD SORE TREATMENT Market, By Region, 2019-2028 (USD Million)

TABLE 27 global OTHERS in COLD SORE TREATMENT Market, By Region, 2019-2028 (USD Million)

TABLE 28 global COLD SORE TREATMENT Market, By distribution channel 2019-2028 (USD Million)

TABLE 29 global Hospitals Pharmacy in COLD SORE TREATMENT Market, By Region, 2019-2028 (USD Million)

TABLE 30 global ONLINE Pharmacy in COLD SORE TREATMENT Market, By Region, 2019-2028 (USD Million)

TABLE 31 global RETAIL Pharmacy in COLD SORE TREATMENT Market, By Region, 2019-2028 (USD Million)

TABLE 32 GLOBAL COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 33 north america cold sore treatment market, country, 2021-2028 (USD Million)

TABLE 34 NORTH AMERICA cold sore treatment market, By strain Type, 2021-2028 (USD MILLION )

TABLE 35 north america cold sore treatment market, By therapeutics, 2021-2028 (USD Million)

TABLE 36 NORTH AMERICA antiviral agents in cold sore treatment market, By therapeutics, 2021-2028 (USD Million)

TABLE 37 NORTH AMERICA analgesic agents in cold sore treatment market, By THERAPEUTICS, 2021-2028 (USD Million)

TABLE 38 NORTH AMERICa cold sore treatment market, By drug type, 2021-2028 (USD Million)

TABLE 39 NORTH AMERICA generics in cold sore treatment market, By drug type, 2021-2028 (USD Million)

TABLE 40 NORTH AMERICA Branded in cold sore treatment market, By drug type, 2021-2028 (USD Million)

TABLE 41 NORTH AMERICA cold sore treatment market, By dosage type, 2021-2028 (USD Million)

TABLE 42 NORTH AMERICA oral in cold sore treatment market, By dosage type, 2021-2028 (USD Million)

TABLE 43 NORTH AMERICA topical in cold sore treatment market, By dosage type, 2021-2028 (USD Million)

TABLE 44 NORTH AMERICA cold sore treatment market, By End user, 2021-2028 (USD Million)

TABLE 45 NORTH AMERICA cold sore treatment market, By distribution channel, 2021-2028 (USD Million)

TABLE 46 U.S. cold sore treatment market, By strain type , 2021-2028 (USD MILLION )

TABLE 47 U.S. cold sore treatment market, By THERAPEUTICS, 2021-2028 (Usd million )

TABLE 48 U.S. anti-viral agents in cold sore treatment market, By THERAPEUTICS, 2021-2028 (USD MILLION )

TABLE 49 U.S. analgesics agents in cold sore treatment market, By THERAPEUTICS , 2021-2028 (USD Million)

TABLE 50 U.S. cold sore treatment market, By drug Type, 2021-2028 (USD Million)

TABLE 51 U.S. Generics in cold sore treatment market, By drug type, 2021-2028 (USD Million)

TABLE 52 U.S. branded in cold sore treatment market, By drug type , 2021-2028 (USD Million)

TABLE 53 U.S. cold sore treatment market, By dosage type , 2021-2028 (USD Million)

TABLE 54 U.S. oral in cold sore treatment market, By dosage type , 2021-2028 (USD Million)

TABLE 55 U.S. topical in cold sore treatment market, By dosage type, 2018-2027 (USD Million)

TABLE 56 U.S. cold sore treatment market, By end user, 2021-2028 (USD Million)

TABLE 57 U.S. cold sore treatment market, By distribution channel, 2021-2028 (USD Million)

TABLE 58 CANADA cold sore treatment market, By testing Type, 2021-2028 (USD MILLION )

TABLE 59 CANADA cold sore treatment market, By THERAPEUTICS, 2021-2028 (Usd million )

TABLE 60 CANADA anti-viral agents in cold sore treatment market, By THERAPEUTICS, 2021-2028 (USD MILLION )

TABLE 61 CANADA analgesics in cold sore treatment market, By THERAPEUTICS , 2021-2028 (USD Million)

TABLE 62 CANADA cold sore treatment market, By drug type , 2021-2028 (USD Million)

TABLE 63 CANADA generics in cold sore treatment market, By drug type Type, 2021-2028 (USD Million)

TABLE 64 CANADA branded in cold sore treatment market, By drug type, 2021-2028 (USD Million)

TABLE 65 CANADA cold sore treatment market, By dosage type , 2021-2028 (USD Million)

TABLE 66 CANADA oral in cold sore treatment market, By dosage type , 2021-2028 (USD Million)

TABLE 67 CANADA topical in cold sore treatment market, By dosage type , 2021-2028 (USD Million)

TABLE 68 canada cold sore treatment market, By end user, 2021-2028 (USD Million)

TABLE 69 CANADA cold sore treatment market, By distribution channel, 2021-2028 (USD Million)

TABLE 70 MEXICO cold sore treatment market, By strain Type, 2021-2028 (USD MILLION )

TABLE 71 MEXICO Cold sore treatment market, By THERAPEUTICS, 2021-2028 (Usd million )

TABLE 72 MEXICO anti-viral agents in cold sore treatment market, By THERAPEUTICS, 2021-2028 (USD MILLION )

TABLE 73 MEXICO analgesics in cold sore treatment market, By THERAPEUTICS , 2021-2028 (USD Million)

TABLE 74 MEXICO cold sore treatment market, By drug type , 2021-2028 (USD Million)

TABLE 75 MEXICO generics in cold sore treatment market, By drug Type, 2021-2028 (USD Million)

TABLE 76 MEXICO branded in cold sore treatment market, By drug type, 2021-2028 (USD Million)

TABLE 77 MEXICO cold sore treatment market, By dosage type , 2021-2028 (USD Million)

TABLE 78 MEXICO oral in cold sore treatment market, By dosage type , 2021-2028 (USD Million)

TABLE 79 MEXICO topical in cold sore treatment market, By dosage type , 2021-2028 (USD Million)

TABLE 80 Mexico cold sore treatment market, By end user, 2021-2028 (USD Million)

TABLE 81 MEXICO cold sore treatment market, By distribution type, 2021-2028 (USD Million)

TABLE 82 EUROPE Cold sore Market, By Country, 2019-2028 (USD Million)

TABLE 83 EUROPE Cold sore Market, By Strain, 2019-2028 (USD Million)

TABLE 84 EUROPE Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 85 EUROPE Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 86 EUROPE Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 87 EUROPE Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 88 EUROPE Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 89 EUROPE Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 90 EUROPE Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 91 EUROPE Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 92 EUROPE Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 93 EUROPE Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 94 EUROPE Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 95 GERMANY Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 96 GERMANY Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 97 GERMANY Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 98 GERMANY Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 99 GERMANY Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 100 GERMANY Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 101 GERMANY Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 102 GERMANY Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 103 GERMANY Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 104 GERMANY Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 105 GERMANY Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 106 GERMANY Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 107 FRANCE Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 108 FRANCE Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 109 FRANCE Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 110 FRANCE Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 111 FRANCE Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 112 FRANCE Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 113 FRANCE Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 114 FRANCE Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 115 FRANCE Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 116 FRANCE Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 117 FRANCE Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 118 FRANCE Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 119 U.K. Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 120 U.K. Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 121 U.K. Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 122 U.K. Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 123 U.K. Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 124 U.K. Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 125 U.K. Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 126 U.K. Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 127 U.K. Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 128 U.K. Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 129 U.K. Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 130 U.K. Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 131 ITALY Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 132 ITALY Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 133 ITALY Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 134 ITALY Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 135 ITALY Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 136 ITALY Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 137 ITALY Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 138 ITALY Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 139 ITALY Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 140 ITALY Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 141 ITALY Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 142 ITALY Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 143 SPAIN Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 144 SPAIN Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 145 SPAIN Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 146 SPAIN Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 147 SPAIN Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 148 SPAIN Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 149 SPAIN Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 150 SPAIN Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 151 SPAIN Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 152 SPAIN Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 153 SPAIN Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 154 SPAIN Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 155 RUSSIA Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 156 RUSSIA Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 157 RUSSIA Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 158 RUSSIA Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 159 RUSSIA Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 160 RUSSIA Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 161 RUSSIA Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 162 RUSSIA Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 163 RUSSIA Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 164 RUSSIA Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 165 RUSSIA Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 166 RUSSIA Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 167 SWITZERLAND Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 168 SWITZERLAND Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 169 SWITZERLAND Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 170 SWITZERLAND Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 171 SWITZERLAND Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 172 SWITZERLAND Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 173 SWITZERLAND Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 174 SWITZERLAND Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 175 SWITZERLAND Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 176 SWITZERLAND Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 177 SWITZERLAND Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 178 SWITZERLAND Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 179 NETHERLAND Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 180 NETHERLAND Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 181 NETHERLAND Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 182 NETHERLAND Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 183 NETHERLAND Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 184 NETHERLAND Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 185 NETHERLAND Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 186 NETHERLAND Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 187 NETHERLAND Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 188 NETHERLAND Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 189 NETHERLAND Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 190 NETHERLAND Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 191 TURKEY Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 192 TURKEY Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 193 TURKEY Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 194 TURKEY Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 195 TURKEY Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 196 TURKEY Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 197 TURKEY Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 198 TURKEY Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 199 TURKEY Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 200 TURKEY Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 201 TURKEY Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 202 TURKEY Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 203 IRELAND Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 204 IRELAND Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 205 IRELAND Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 206 IRELAND Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 207 IRELAND Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 208 IRELAND Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 209 IRELAND Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 210 IRELAND Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 211 IRELAND Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 212 IRELAND Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 213 IRELAND Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 214 IRELAND Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 215 BELGIUM Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 216 BELGIUM Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 217 BELGIUM Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 218 BELGIUM Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 219 BELGIUM Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 220 BELGIUM Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 221 BELGIUM Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 222 BELGIUM Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 223 BELGIUM Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 224 BELGIUM Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 225 BELGIUM Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 226 BELGIUM Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 227 POLAND Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 228 POLAND Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 229 POLAND Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 230 POLAND Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 231 POLAND Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 232 POLAND Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 233 POLAND Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 234 POLAND Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 235 POLAND Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 236 POLAND Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 237 POLAND Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 238 POLAND Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 239 AUSTRIA Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 240 AUSTRIA Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 241 AUSTRIA Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 242 AUSTRIA Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 243 AUSTRIA Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 244 AUSTRIA Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 245 AUSTRIA Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 246 AUSTRIA Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 247 AUSTRIA Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 248 AUSTRIA Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 249 AUSTRIA Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 250 AUSTRIA Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 251 NORWAY Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 252 NORWAY Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 253 NORWAY Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 254 NORWAY Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 255 NORWAY Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 256 NORWAY Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 257 NORWAY Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 258 NORWAY Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 259 NORWAY Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 260 NORWAY Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 261 NORWAY Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 262 NORWAY Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 263 HUNGARY Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 264 HUNGARY Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 265 HUNGARY Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 266 HUNGARY Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 267 HUNGARY Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 268 HUNGARY Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 269 HUNGARY Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 270 HUNGARY Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 271 HUNGARY Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 272 HUNGARY Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 273 HUNGARY Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 274 HUNGARY Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 275 LITHUANIA Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 276 LITHUANIA Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 277 LITHUANIA Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 278 LITHUANIA Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 279 LITHUANIA Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 280 LITHUANIA Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 281 LITHUANIA Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 282 LITHUANIA Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 283 LITHUANIA Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 284 LITHUANIA Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 285 LITHUANIA Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 286 LITHUANIA Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 287 REST OF EUROPE Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 288 asia pacific Cold sore Market, By Country, 2019-2028 (USD Million)

TABLE 289 Asia Pacific Cold sore Market, By Strain, 2019-2028 (USD Million)

TABLE 290 Asia Pacific Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 291 Asia Pacific Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 292 Asia Pacific Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 293 Asia Pacific Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 294 Asia Pacific Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 295 Asia Pacific Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 296 Asia Pacific Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 297 Asia Pacific Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 298 Asia Pacific Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 299 Asia Pacific Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 300 Asia Pacific Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 301 China Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 302 China Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 303 China Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 304 China Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 305 China Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 306 China Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 307 China Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 308 China Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 309 China Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 310 China Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 311 China Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 312 China Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 313 Japan Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 314 Japan Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 315 Japan Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 316 Japan Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 317 Japan Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 318 Japan Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 319 Japan Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 320 Japan Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 321 Japan Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 322 Japan Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 323 Japan Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 324 Japan Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 325 India Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 326 India Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 327 India Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 328 India Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 329 India Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 330 India Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 331 India Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 332 India Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 333 India Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 334 India Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 335 India Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 336 India Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 337 Peru Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 338 Peru Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 339 Australia Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 340 Australia Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 341 Australia Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 342 Australia Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 343 Australia Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 344 Australia Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 345 Australia Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 346 Australia Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 347 Australia Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 348 Australia Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 349 South Korea Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 350 South Korea Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 351 South Korea Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 352 South Korea Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 353 South Korea Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 354 South Korea Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 355 South Korea Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 356 South Korea Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 357 South Korea Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 358 South Korea Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 359 South Korea Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 360 South Korea Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 361 SIngapore Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 362 SIngapore Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 363 SIngapore Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 364 SIngapore Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 365 SIngapore Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 366 SIngapore Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 367 SIngapore Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 368 SIngapore Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 369 SIngapore Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 370 SIngapore Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 371 SIngapore Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 372 SIngapore Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 373 Malaysia Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 374 Malaysia Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 375 Malaysia Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 376 Malaysia Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 377 Malaysia Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 378 Malaysia Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 379 Malaysia Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 380 Malaysia Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 381 Malaysia Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 382 Malaysia Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 383 Malaysia Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 384 Malaysia Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 385 Philippiness Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 386 Philippiness Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 387 Philippiness Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 388 Philippiness Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 389 Philippiness Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 390 Philippiness Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 391 Philippiness Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 392 Philippiness Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 393 Philippiness Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 394 Philippiness Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 395 Philippiness Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 396 Philippiness Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 397 Indonesia Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 398 Indonesia Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 399 Indonesia Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 400 Indonesia Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 401 Indonesia Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 402 Indonesia Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 403 Indonesia Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 404 Indonesia Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 405 Indonesia Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 406 Indonesia Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 407 Indonesia Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 408 Indonesia Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 409 Thailand Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 410 Thailand Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 411 Thailand Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 412 Thailand Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 413 Thailand Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 414 Thailand Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 415 Thailand Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 416 Thailand Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 417 Thailand Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 418 Thailand Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 419 Thailand Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 420 Thailand Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 421 Vietnam Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 422 Vietnam Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 423 Vietnam Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 424 Vietnam Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 425 Vietnam Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 426 Vietnam Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 427 Vietnam Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 428 Vietnam Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 429 Vietnam Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 430 Vietnam Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 431 Vietnam Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 432 Vietnam Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 433 Rest of Asia-Pacific Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 434 South America Cold Sore Market, By Country, 2019-2028 (USD Million)

TABLE 435 South America Cold Sore Market, By Strain, 2019-2028 (USD Million)

TABLE 436 South America Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 437 South America Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 438 South America Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 439 South America Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 440 South America Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 441 South America Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 442 South America Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 443 South America Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 444 South America Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 445 South America Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 446 South America Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 447 Brazil Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 448 Brazil Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 449 Brazil Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 450 Brazil Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 451 Brazil Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 452 Brazil Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 453 Brazil Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 454 Brazil Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 455 Brazil Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 456 Brazil Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 457 Brazil Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 458 Brazil Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 459 Argentina Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 460 Argentina Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 461 Argentina Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 462 Argentina Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 463 Argentina Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 464 Argentina Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 465 Argentina Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 466 Argentina Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 467 Argentina Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 468 Argentina Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 469 Argentina Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 470 Argentina Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 471 Peru Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 472 Peru Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 473 Peru Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 474 Peru Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 475 Peru Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 476 Peru Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 477 Peru Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 478 Peru Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 479 Peru Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 480 Peru Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 481 Peru Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 482 Peru Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 483 Rest of South America Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 484 Middle East & Africa cold sore treatment market, country, 2021-2028 (USD Million)

TABLE 485 MIDDLE EAST & AFRICA cold sore treatment market, By strain Type, 2021-2028 (USD MILLION )

TABLE 486 Middle East & Africa cold sore treatment market, By therapeutics, 2021-2028 (USD Million)

TABLE 487 MIDDLE EAST & AFRICA antiviral agents in cold sore treatment market, By therapeutics, 2021-2028 (USD Million)

TABLE 488 MIDDLE EAST & AFRICA analgesic agents in cold sore treatment market, By THERAPEUTICS, 2021-2028 (USD Million)

TABLE 489 Middle East & Africa cold sore treatment market, By drug type, 2021-2028 (USD Million)

TABLE 490 MIDDLE EAST & AFRICA generics in cold sore treatment market, By drug type, 2021-2028 (USD Million)

TABLE 491 MIDDLE EAST & AFRICA Branded in cold sore treatment market, By drug type, 2021-2028 (USD Million)

TABLE 492 MIDDLE EAST & AFRICA cold sore treatment market, By dosage type, 2021-2028 (USD Million)

TABLE 493 MIDDLE EAST & AFRICA oral in cold sore treatment market, By dosage type, 2021-2028 (USD Million)

TABLE 494 MIDDLE EAST & AFRICA topical in cold sore treatment market, By dosage type, 2021-2028 (USD Million)

TABLE 495 MIDDLE EAST & AFRICA cold sore treatment market, By End user, 2021-2028 (USD Million)

TABLE 496 MIDDLE EAST & AFRICA cold sore treatment market, By distribution channel, 2021-2028 (USD Million)

TABLE 497 South Africa cold sore treatment market, By strain type , 2021-2028 (USD MILLION )

TABLE 498 SOUTH AFRICA cold sore treatment market, By THERAPEUTICS, 2021-2028 (Usd million )

TABLE 499 SOUTH AFRICA anti-viral agents in cold sore treatment market, By THERAPEUTICS, 2021-2028 (USD MILLION )

TABLE 500 SOUTH AFRICA analgesics agents in cold sore treatment market, By THERAPEUTICS , 2021-2028 (USD Million)

TABLE 501 SOUTH AFRICA cold sore treatment market, By drug Type, 2021-2028 (USD Million)

TABLE 502 SOUTH AFRICA Generics in cold sore treatment market, By drug type, 2021-2028 (USD Million)

TABLE 503 SOUTH AFRICA branded in cold sore treatment market, By drug type , 2021-2028 (USD Million)

TABLE 504 SOUTH AFRICA cold sore treatment market, By dosage type , 2021-2028 (USD Million)

TABLE 505 SOUTH AFRICA oral in cold sore treatment market, By dosage type , 2021-2028 (USD Million)

TABLE 506 SOUTH AFRICA topical in cold sore treatment market, By dosage type, 2018-2027 (USD Million)

TABLE 507 SOUTH AFRICA cold sore treatment market, By end user, 2021-2028 (USD Million)

TABLE 508 south africa cold sore treatment market, By distribution channel, 2021-2028 (USD Million)

TABLE 509 egypt cold sore treatment market, By testing Type, 2021-2028 (USD MILLION )

TABLE 510 egypt cold sore treatment market, By THERAPEUTICS, 2021-2028 (Usd million )

TABLE 511 egypt anti-viral agents in cold sore treatment market, By THERAPEUTICS, 2021-2028 (USD MILLION )

TABLE 512 egypt analgesics in cold sore treatment market, By THERAPEUTICS , 2021-2028 (USD Million)

TABLE 513 egypt cold sore treatment market, By drug type , 2021-2028 (USD Million)

TABLE 514 egypt generics in cold sore treatment market, By drug type Type, 2021-2028 (USD Million)

TABLE 515 egypt branded in cold sore treatment market, By drug type, 2021-2028 (USD Million)

TABLE 516 egypt cold sore treatment market, By dosage type , 2021-2028 (USD Million)

TABLE 517 egypt oral in cold sore treatment market, By dosage type , 2021-2028 (USD Million)

TABLE 518 egypt topical in cold sore treatment market, By dosage type , 2021-2028 (USD Million)

TABLE 519 egypt cold sore treatment market, By end user, 2021-2028 (USD Million)

TABLE 520 egypt cold sore treatment market, By distribution channel, 2021-2028 (USD Million)

TABLE 521 SAUDI ARABIA cold sore treatment market, By strain Type, 2021-2028 (USD MILLION )

TABLE 522 SAUDI ARABIA Cold sore treatment market, By THERAPEUTICS, 2021-2028 (Usd million )

TABLE 523 SAUDI ARABIA anti-viral agents in cold sore treatment market, By THERAPEUTICS, 2021-2028 (USD MILLION )

TABLE 524 SAUDI ARABIA analgesics in cold sore treatment market, By THERAPEUTICS , 2021-2028 (USD Million)

TABLE 525 SAUDI ARABIA cold sore treatment market, By drug type , 2021-2028 (USD Million)

TABLE 526 SAUDI ARABIA generics in cold sore treatment market, By drug Type, 2021-2028 (USD Million)

TABLE 527 SAUDI ARABIA branded in cold sore treatment market, By drug type, 2021-2028 (USD Million)

TABLE 528 SAUDI ARABIA cold sore treatment market, By dosage type , 2021-2028 (USD Million)

TABLE 529 SAUDI ARABIA oral in cold sore treatment market, By dosage type , 2021-2028 (USD Million)

TABLE 530 SAUDI ARABIA topical in cold sore treatment market, By dosage type , 2021-2028 (USD Million)

TABLE 531 SAUDI ARABIA cold sore treatment market, By end user, 2021-2028 (USD Million)

TABLE 532 saudi arabia cold sore treatment market, By distribution type, 2021-2028 (USD Million)

TABLE 533 ISRAEL cold sore treatment market, By strain Type, 2021-2028 (USD MILLION )

TABLE 534 ISRAEL Cold sore treatment market, By THERAPEUTICS, 2021-2028 (Usd million )

TABLE 535 ISRAEL anti-viral agents in cold sore treatment market, By THERAPEUTICS, 2021-2028 (USD MILLION )

TABLE 536 ISRAEL analgesics in cold sore treatment market, By THERAPEUTICS , 2021-2028 (USD Million)

TABLE 537 ISRAEL cold sore treatment market, By drug type , 2021-2028 (USD Million)

TABLE 538 ISRAEL generics in cold sore treatment market, By drug Type, 2021-2028 (USD Million)

TABLE 539 ISRAEL branded in cold sore treatment market, By drug type, 2021-2028 (USD Million)

TABLE 540 ISRAEL cold sore treatment market, By dosage type , 2021-2028 (USD Million)

TABLE 541 ISRAEL oral in cold sore treatment market, By dosage type , 2021-2028 (USD Million)

TABLE 542 ISRAEL topical in cold sore treatment market, By dosage type , 2021-2028 (USD Million)

TABLE 543 ISRAEL cold sore treatment market, By end user, 2021-2028 (USD Million)

TABLE 544 israel cold sore treatment market, By distribution type, 2021-2028 (USD Million)

TABLE 545 UAE cold sore treatment market, By strain Type, 2021-2028 (USD MILLION )

TABLE 546 UAE Cold sore treatment market, By THERAPEUTICS, 2021-2028 (Usd million )

TABLE 547 UAE anti-viral agents in cold sore treatment market, By THERAPEUTICS, 2021-2028 (USD MILLION )

TABLE 548 UAE analgesics in cold sore treatment market, By THERAPEUTICS , 2021-2028 (USD Million)

TABLE 549 UAE cold sore treatment market, By drug type , 2021-2028 (USD Million)

TABLE 550 UAE generics in cold sore treatment market, By drug Type, 2021-2028 (USD Million)

TABLE 551 UAE branded in cold sore treatment market, By drug type, 2021-2028 (USD Million)

TABLE 552 UAE cold sore treatment market, By dosage type , 2021-2028 (USD Million)

TABLE 553 UAE oral in cold sore treatment market, By dosage type , 2021-2028 (USD Million)

TABLE 554 UAE topical in cold sore treatment market, By dosage type , 2021-2028 (USD Million)

TABLE 555 UAE cold sore treatment market, By end user, 2021-2028 (USD Million)

TABLE 556 uae cold sore treatment market, By distribution type, 2021-2028 (USD Million)

TABLE 557 KUWAIT cold sore treatment market, By strain Type, 2021-2028 (USD MILLION )

TABLE 558 KUWAIT Cold sore treatment market, By THERAPEUTICS, 2021-2028 (Usd million )

TABLE 559 KUWAIT anti-viral agents in cold sore treatment market, By THERAPEUTICS, 2021-2028 (USD MILLION )

TABLE 560 KUWAIT analgesics in cold sore treatment market, By THERAPEUTICS , 2021-2028 (USD Million)

TABLE 561 KUWAIT cold sore treatment market, By drug type , 2021-2028 (USD Million)

TABLE 562 KUWAIT generics in cold sore treatment market, By drug Type, 2021-2028 (USD Million)

TABLE 563 KUWAIT branded in cold sore treatment market, By drug type, 2021-2028 (USD Million)

TABLE 564 KUWAIT cold sore treatment market, By dosage type , 2021-2028 (USD Million)

TABLE 565 KUWAIT oral in cold sore treatment market, By dosage type , 2021-2028 (USD Million)

TABLE 566 KUWAIT topical in cold sore treatment market, By dosage type , 2021-2028 (USD Million)

TABLE 567 KUWAIT cold sore treatment market, By end user, 2021-2028 (USD Million)

TABLE 568 KUWAIT cold sore treatment market, By distribution type, 2021-2028 (USD Million)

TABLE 569 REST OF MIDDLE EAST & AFRICA cold sore treatment market, By strain Type, 2021-2028 (USD MILLION )

Lista de Figura

FIGURE 1 Global COLD SORE TREATMENT MARKET: SEGMENTATION

FIGURE 2 GLOBAL COLD SORE TREATMENT MARKET : DATA TRIANGULATION

FIGURE 3 global Cold Sore Treatment Market: DROC ANALYSIS

FIGURE 4 Global Cold Sore Treatment market: Global VS REGIONAL MARKET ANALYSIS

FIGURE 5 Global Cold Sore Treatment Market: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL Cold Sore Treatment MARKET: MULTIVARIATE MODELLING

FIGURE 7 GLOBAL Cold Sore Treatment MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 GLOBAL COLD SORE TREATMENT MARKET: DBMR MARKET POSITION GRID

FIGURE 9 GLOBAL COLD SORE TREATMENT MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 GLOBAL Cold Sore Treatment MARKET: MARKET drug type COVERAGE GRID

FIGURE 11 Global Cold Sore Treatment market: SEGMENTATION

FIGURE 12 NORTH AMERICA is expected to DOMINATE THE GLOBAL Cold Sore treatment market AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 13 Growing PREVALENCE OF COLD SORE TREATMENT WORLDWIDE, AND PROLIFERATION IN MODES OF TRANSMISSION of herpes simplex virus (hsv), and increasing awareness about sexually transmitted diseases are DRIVing THE global Cold Sore treatment market IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 14 HERPES SIMPLEX TYPE 1 VIRUS SEGMENT is expected to account for the largest share of the global COLD SORE TREATMENT MARKET in 2021 & 2028

FIGURE 15 asia-pacific is the fastest growing market FOR the Cold Sore Treatment MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF GLOBAL COLD SORE TREATMENT MARKET

FIGURE 17 PREVALENCE OF HERPES SIMPLEX VIRUS TYPE 1, AMONG PERSONS AGED 14-49 YEARS, BY AGE GROUP: IN THE U.S. 2015–2016

FIGURE 18 PREVALENCE OF HERPES SIMPLEX VIRUS TYPE 1, BY RACE AND HISPANIC ORIGIN: U.S. 2015–2016

FIGURE 19 PREVALENCE OF HERPES SIMPLEX VIRUS TYPE 1, BY SEX: IN DIFFERENT COUNTRIES 2015–2016

FIGURE 20 global COLD SORE TREATMENT market: BY strain TYPE, 2020

FIGURE 21 global COLD SORE TREATMENT market: BY strain TYPE, 2020-2028 (USD Million)

FIGURE 22 global COLD SORE TREATMENT market: BY strain TYPE, CAGR (2021-2028)

FIGURE 23 global COLD SORE TREATMENT market: BY strain TYPE, LIFELINE CURVE

FIGURE 24 global COLD SORE TREATMENT market: BY THERAPEUTICS, 2020

FIGURE 25 global COLD SORE TREATMENT market: BY THERAPEUTICS , 2020-2028 (USD Million)

FIGURE 26 global COLD SORETREATMENT market: BY THERAPEUTICS, CAGR (2021-2028)

FIGURE 27 global COLD SORETREATMENT market: BY THERAPEUTICS, LIFELINE CURVE

FIGURE 28 global COLD SORETREATMENT market: BY drug type, 2020

FIGURE 29 global COLD SORETREATMENT market: BY drug type 2020-2028 (USD Million)

FIGURE 30 global COLD SORETREATMENT market: BY drug type, CAGR (2021-2028)

FIGURE 31 global COLD SORETREATMENT market: BY drug type, LIFELINE CURVE

FIGURE 32 global COLD SORETREATMENT market: BY dosage type, 2020

FIGURE 33 global COLD SORETREATMENT market: BY dosage type 2020-2028 (USD Million)

FIGURE 34 global COLD SORETREATMENT market: BY dosage type, CAGR (2021-2028)

FIGURE 35 global COLD SORETREATMENT market: BY dosage type, LIFELINE CURVE

FIGURE 36 global COLD SORE TREATMENT market: BY END USER, 2020

FIGURE 37 global COLD SORE TREATMENT market: BY END USER 2020-2028 (USD Million)

FIGURE 38 global COLD SORE TREATMENT market: BY END USER, CAGR (2021-2028)

FIGURE 39 global COLD SORE TREATMENT market: BY END USER, LIFELINE CURVE

FIGURE 40 global COLD SORE TREATMENT market: BY distribution channel, 2020

FIGURE 41 global COLD SORE TREATMENT market: BY distribution channel 2020-2028 (USD Million)

FIGURE 42 global COLD SORE TREATMENT market: BY distribution channel, CAGR (2021-2028)

FIGURE 43 global COLD SORE TREATMENT market: BY distribution channel, LIFELINE CURVE

FIGURE 44 GLOBAL Cold sore treatment market: SNAPSHOT (2020)

FIGURE 45 GLOBAL Cold sore treatment market: BY Region (2020)

FIGURE 46 GLOBAL Cold sore treatment market: BY Region (2020 & 2028)

FIGURE 47 GLOBAL Cold sore treatment market: BY Region (2020 & 2028)

FIGURE 48 GLOBAL Cold sore treatment market: BY strain type (2021-2028)

FIGURE 49 NORTH AMERICA cold sore treatment market: SNAPSHOT (2020)

FIGURE 50 NORTH AMERICA cold sore treatment market: BY country (2020)

FIGURE 51 NORTH AMERICA cold sore treatment market: BY country (2021 & 2028)

FIGURE 52 NORTH AMERICA cold sore treatment market: BY country (2021 & 2028)

FIGURE 53 NORTH AMERICA cold sore treatment market: BY strain type (2021-2028)

FIGURE 54 EUROPE cold sore treatment market: SNAPSHOT (2020)

FIGURE 55 EUROPE cold sore treatment market: BY COUNTRY (2020)

FIGURE 56 EUROPE cold sore treatment market: BY COUNTRY (2021 & 2028)

FIGURE 57 EUROPE cold sore treatment market: BY COUNTRY (2021 & 2028)

FIGURE 58 EUROPE cold sore treatment market: BY strains (2021-2028)

FIGURE 59 Asia pacific cold sore treatment market: SNAPSHOT (2020)

FIGURE 60 Asia pacific cold sore treatment market: BY COUNTRY (2020)

FIGURE 61 Asia pacific cold sore treatment market: BY COUNTRY (2021 & 2028)

FIGURE 62 Asia pacific cold sore treatment market: BY COUNTRY (2021 & 2028)

FIGURE 63 Asia pacific cold sore treatment market: BY strains (2021-2028)

FIGURE 64 SOUTH AMERICA cold Sore treatment market: SNAPSHOT (2020)

FIGURE 65 SOUTH AMERICA cold Sore treatment market: BY COUNTRY (2020)

FIGURE 66 SOUTH AMERICA cold Sore treatment market: BY COUNTRY (2021 & 2028)

FIGURE 67 SOUTH AMERICA cold Sore treatment market: BY COUNTRY (2021 & 2028)

FIGURE 68 SOUTH AMERICA cold Sore treatment market: BY strains (2021-2028)

FIGURE 69 MIDDLE EAST & AFRICA cold sore treatment market: SNAPSHOT (2020)

FIGURE 70 MIDDLE EAST & AFRICA cold sore treatment market: BY country (2020)

FIGURE 71 MIDDLE EAST & AFRICA cold sore treatment market: BY country (2021-2028)

FIGURE 72 MIDDLE EAST & AFRICA cold sore treatment market: BY country (2021 & 2028)

FIGURE 73 MIDDLE EAST & AFRICA cold sore treatment market: BY strain type (2021-2028)

FIGURE 74 Global cold sore treatment market: company share 2020 (%)

FIGURE 75 north america cold sore treatment market: company share 2020 (%)

FIGURE 76 europe cold sore treatment market: company share 2020 (%)

FIGURE 77 Asia-Pacific cold sore treatment market: company share 2020 (%)

View Detailed Information Right Arrow

Metodologia de Investigação

A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados ​​e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.

A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis ​​de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.

Personalização disponível

A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.

Perguntas frequentes

The cold sore treatment market size will be worth USD 1,376.06 million by 2030.
The growth rate of the cold sore treatment market is 6.60% in the forecasted period by 2030.
The high prevalence rate of hsv infection & increasing investment in healthcare infrastructure are the growth drivers of the cold sore treatment market.
Strain type, therapeutics type, drug type, dosage form, route of administration, end-users, and distribution channel are the factors on which the cold sore treatment market research is based.
Major companies in the cold sore treatment market are Pfizer Inc. (U.S.), GlaxoSmithKline plc (U.K.), Novartis AG (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Sanofi (France), AstraZeneca (U.K.), Johnson & Johnson Private Limited (U.S.), Merck & Co., Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Cipla Inc. (U.S.), Hologic, Inc. (U.S.), BD (U.S.), Bristol-Myers Squibb Company (U.S.), Gilead Sciences, Inc. (U.S.), Bayer AG (Germany), Eli Lilly and Company (U.S.), Sun Pharmaceutical Industries Ltd. (India), Aurobindo Pharma (India), Lupin (India), Bausch Health Companies Inc. (Canada).